ArticleFrontiers in oncology2022

MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma.

Tao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.